Katsuyoshi Ando

18PUBLICATIONS
39CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer diagnosisCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 13, 2026
Splicing Factor 3a Subunit 1 Promotes Colorectal Cancer Growth via Anti-Apoptotic Effects of Syntaxin12.

Takahiro Sasaki, Hiroaki Konishi, Tatsuya Dokoshi

|Feb 03, 2026
Association of tissue lymphocyte immunophenotype and clinical outcomes: A prospective study in patients with ulcerative colitis treated with vedolizumab.

Katsuyoshi Ando, Shin Kashima, Aki Sakatani

|Jan 17, 2026
Intestinal transcriptomic analysis and prediction of biomarkers associated with mucosal healing following vedolizumab treatment in ulcerative colitis using machine learning.

Katsuyoshi Ando, Shin Kashima, Aki Sakatani

|Sep 08, 2025
Successful Identification and Treatment of Cancer of Unknown Primary Originating From Gastric Cancer Using Comprehensive Genomic Profiling and Immune Checkpoint Inhibitor Therapy: A Case Report.

Takahiro Sasaki, Sayaka Yuzawa, Hiroki Tanabe

|Mar 20, 2025
Comparison of traction vs. snare as rescue methods for challenging colorectal endoscopic submucosal dissection: Propensity score-matched study.

Keitaro Takahashi, Takuya Iwama, Kazuyuki Tanaka

|Jan 14, 2025
hsa_circ_0015388 Reduces Macrophage Derived Reactive Oxygen Species in Crohn's Disease.

Yuya Sugiyama, Hiroaki Konishi, Tatsuya Dokoshi

Pageof 3

Frequent Collaborators

9 joint publications

Mikihiro Fujiya

8 joint publications

Hiroki Tanabe

7 joint publications

Keitaro Takahashi

5 joint publications

Shin Kashima